Breast (BCa) and prostate (PCa) cancers are hormone receptor (HR)-driven cancers. Thus, BCa and PCa patients are given therapies that reduce hormone levels or directly block HR activity; but most patients eventually develop treatment resistance. | IL-1-conferred gene expression pattern in ERα BCa and AR PCa cells is intrinsic to ERα BCa and AR PCa cells and promotes cell survival